Irritable bowel syndrome gains new treatment - - Modern Medicine

Irritable bowel syndrome gains new treatment
Publish date: May 12, 2008
By:  Judy Chi
Source: Drug Topics

Amitiza (lubiprostone), formerly approved to treat chronic idiopathic constipation, has gained clearance for a new indication. The drug can now be used to treat irritable bowel syndrome with constipation (IBS-C) in adult women. According to Sucampo Pharmaceuticals and Takeda Pharmaceuticals America, the product is the only approved treatment for IBS-C in this country.

post a comment
Please complete the form below to post your comment.
Bold = Required
Email Address Your email address will NOT be published.
Display Name appears with your comment
City
State
Country
Remember me: YesNo
Comment read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
eSamples check closet
eSamples check closet
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here

Featured Jobs

More Jobs

Clinical Perspectives
AcneAdolescent MedicineAllergy & ImmunologyAlzheimer's DiseaseAsthmaBPHBreast CancerCardiologyCataractsChild Behavior & DevelopmentClinical PharmacologyContraceptionCorneal DiseaseCosmetic DermatologyCosmetic SurgeryDepressionDermatology DiabetesDry EyeEczema/Atopic DermatitisEndocrinologyEpilepsyErectile DysfunctionGastroenterologyGastroesophageal Reflux Disease (GERD) & Acid Peptic DiseaseGeriatricsGlaucomaGynecologic OncologyHIV/AIDSHormone TherapyHyperlipidemiaHypertensionImmunization/VaccinesInfectious DiseaseInternal MedicineIrritable Bowel Syndrome (IBS)Kidney & Bladder CancerLaser & Light Technology in DermatologyMaternal & Fetal MedicineMenopauseMigraineMultiple SclerosisNeurologyNutritionOb/Gyn SurgeryObesityOB/GYN & Women's HealthOncologyOphthalmologyOptometryOrthopedicsOsteoporosisParkinson's DiseasePathologyPediatricsPrimary Care MedicineProstate CancerPsoriasisPsychiatry & Behavioral HealthRadiologyRefractive SurgeryReproductive Endocrinology/InfertilityRetinal DiseaseRheumatoid ArthritisSkin CancerSleep DisordersSmoking-Related IllnessStrokeSurgeryUrinary Incontinence/Overactive BladderUrologic SurgeryUrology
Business Perspectives
Coding CounselorLiability & Risk ManagementHealth Care Information TechnologyPractice ManagementBusiness OperationsHuman ResourcesHealth Law & PolicyManaged CarePersonal Finance Products
Popular Topics
CME/CECoding CounseloreNewslettersPatient Education CenterBlogsBlogsFormulary CounselorModernMedicine RadioSyndicationSurgical Video Center


Source: Drug Topics, 5/12/2008
Click here